UBS Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $184K | Sell |
|
|||||
|
2023
Q4 | $177K | Buy |
|
|||||
|
2023
Q3 | $72.1K | Sell |
|
|||||
|
2023
Q2 | $80.7K | Buy |
|
|||||
|
2023
Q1 | $38.4K | Buy |
|
|||||
|
2022
Q4 | $8.88K | Sell |
|
|||||
|
2022
Q3 | $19K | Buy |
|
|||||
|
2022
Q2 | $8K | Sell |
|
|||||
|
2022
Q1 | $15K | Buy |
|
|||||
|
2021
Q4 | $1K | Hold |
|
|||||
|
2021
Q3 | $1K | Sell |
|
|||||
|
2021
Q2 | $3K | Sell |
|
|||||
|
2021
Q1 | $10K | Buy |
|
|||||
|
2020
Q4 | $1K | Hold |
|
|||||
|
2020
Q3 | $1K | Hold |
|
|||||
|
2020
Q2 | $1K | Sell |
|
|||||
|
2020
Q1 | $5K | Buy |
|
|||||
|
2019
Q4 | $1K | Sell |
|
|||||
|
2019
Q3 | $13K | Buy |
|
|||||
|
2019
Q2 | $4K | Sell |
|
|||||
|
2019
Q1 | $14K | Sell |
|
|||||
|
2018
Q4 | $15K | Buy |
|
|||||
|
2018
Q3 | $12K | Buy |
|
|||||
|
2018
Q2 | $11K | Buy |
|
|||||
|
2018
Q1 | $4K | Sell |
|
|||||
|
2017
Q4 | $70K | Sell |
|
|||||
|
2017
Q3 | $105K | Buy |
|
|||||
|
2017
Q2 | $66K | Sell |
|
|||||
|
2017
Q1 | $468K | Sell |
|
|||||
|
2016
Q4 | $943K | Buy |
|
|||||
|
2016
Q3 | $615K | Sell |
|
|||||
|
2016
Q2 | $1.04M | Buy |
|
|||||
|
2016
Q1 | $1.16M | Sell |
|
|||||
|
2015
Q4 | $2.69M | Buy |
|
|||||
|
2015
Q3 | $1.65M | Sell |
|
|||||
|
2015
Q2 | $2.4M | Sell |
|
|||||
|
2015
Q1 | $2.55M | Buy |
|
|||||
|
2014
Q4 | $1.89M | Buy |
|